|1.||Vonderheide, Robert H: 2 articles (12/2007 - 02/2004)|
|2.||Domchek, Susan M: 2 articles (12/2007 - 02/2004)|
|3.||Chen, Dih-Yih: 2 articles (12/2007 - 02/2004)|
|4.||Thompson, Lara B S: 1 article (12/2007)|
|5.||Vance, Barbara A: 1 article (12/2007)|
|6.||Hoar, Kara M: 1 article (02/2004)|
|7.||Stephans, Katherine F: 1 article (02/2004)|
|8.||Anderson, Karen S: 1 article (02/2004)|
|9.||Xia, Zhinan: 1 article (02/2004)|
|10.||George, Daniel J: 1 article (02/2004)|
10/14/2002 - "More data are required to elucidate whether hTERT peptide (540-548) -specific T cells can indeed recognize and destroy tumor cells. "
10/14/2002 - "Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells?"
12/01/2007 - "An HLA-A2-binding peptide from Htert (I540, ILAKFLHWL) has been used to generate peptide-specific T cells in vitro and in vivo in patients that lyse telomerase-positive tumors in an MHC-restricted fashion. "
02/01/2004 - "A Phase I clinical trial was performed to evaluate the clinical and immunological impact of vaccinating advanced cancer patients with the HLA-A2-restricted hTERT I540 peptide presented with keyhole limpet hemocyanin by ex vivo generated autologous dendritic cells. "
|1.||Telomerase (Telomerase Reverse Transcriptase)
|2.||keyhole-limpet hemocyanin (keyhole limpet hemocyanin)